The differential diagnosis of skin lesions in human immunodeficiency virus patients is diverse and includes both infectious and non infectious causes. In this case presentation, a 37 year old male newly diagnosed with HIV presented to a hospital in the United States with skin lesions and worsening lower extremity swelling. After presentation, he developed respiratory distress and was found to have disseminated Kaposi sarcoma with cutaneous and pulmonary involvement. Kaposi sarcoma has decreased in incidence in the era of highly active antiretroviral therapy. However, it remains an important acquired immunodeficiency syndrome defining illness which may be the presenting complaint in a patient with occult HIV infection. Kaposi sarcoma has substantial mortality and morbidity and should be included in the differential diagnosis of skin lesions in a HIV positive patient.
InTRoducTIon
In this case report, we describe a patient recently diagnosed with human immunodeficiency syndrome (HIV) who presented with progressive lower extremity swelling. During his hospitalization his respiratory status deteriorated and was found to have Kaposi Sarcoma (KS) with cutaneous and pulmonary involvement. KS remains an important acquired immunodeficiency syndrome (AIDS) defining illness and must be included in the differential diagnosis of skin lesions in HIV patients. In the setting of HIV, it is treated with initiation of highly active antiretroviral therapy (HAART) and in some cases systemic chemotherapy. KS continues to be an important cause of morbidity and mortality in HIV patients.
cAse RePoRT
A 37 year-old Ghanaian male diagnosed with HIV three weeks prior presented with one month of worsening bilateral lower extremity edema and stiffness to a Boston area hospital in the United States in February 2010. He was admitted to an outside hospital three weeks prior to presentation with nonproductive cough, shortness of breath and chills. At that time, he was found to be HIV positive and was treated with azithromycin for community acquired pneumonia and trimethoprim-sulfamethoxazole (TMP-SMX) and prednisone for presumed Pneumocystis jirovecii pneumonia. His CD4 count and viral load were not available. On his presentation to our hospital, he described a one month history of worsening lower extremity edema which gradually worsened to extend to his bilateral hips. On review of systems, he noted a two to three month history of weight loss and decreased appetite. He also stated that the non productive cough and dyspnea on exertion had not resolved.
He denied fevers, chills, nausea, vomiting, diarrhea or history of trauma to either lower extremity. He emigrated from Ghana to the United Kingdom 10 years ago and moved to Boston two years ago.
In the emergency department, his temperature was 38. KS in patients on immunosuppressive medications is thought to be a complication of their effect on the host immune system. In transplant patients, recipients of kidney transplants are most commonly affected and skin involvement is more common (85% in one series) than visceral disease. 7 Skin lesions seen in patients on immunosuppressive medications are similar to those seen in classic and AIDS-related KS.
AIDS-related KS is generally multifocal, rapidly progressive and occurs commonly with visceral involvement. Although it was present as an AIDS defining illness in more than 20% of European patients early in the HIV epidemic, its incidence has decreased in the era of HAART. 8 However, KS is still the most common AIDS figure 2. chest radiograph on admission to the hospital showed extensive diffuse bilateral interstitial infiltrates
